These results suggest that glioma PTPRZ in the xenograft model receives additional glycosylation, such as the HNK-1 epitope, which then hinders the epitopes for antiphosphacan and anti-PTPRZ (Sigma). This evidence concerns the gene B3GAT1 and central nervous system cancer.